Evidence map›Paper›PMID 40574489›Full record

ArticleAnnals of clinical and translational neurology2025

Timing and Predictive Value of Clinical Conditions Preceding Multiple Sclerosis in the UK Biobank.

Andrea Nova, Teresa Fazia, Giovanni Di Caprio, Davide Gentilini, Luisa Bernardinelli, Roberto Bergamaschi

Abstract read
In one paragraph

Article in Annals of clinical and translational neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Andrea NovaDepartment of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.ORCID 0000-0002-7258-1938
Teresa FaziaDepartment of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
Giovanni Di CaprioDepartment of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.ORCID 0009-0003-1913-9897
Davide GentiliniDepartment of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
Luisa BernardinelliDepartment of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
Roberto BergamaschiMultiple Sclerosis Research Center, IRCCS Mondino Foundation, Pavia, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesMultiple sclerosis (MS) patients often experience a higher incidence of clinical conditions before diagnosis, suggesting a prodromal phase. However, their predictive value and temporal trajectories remain underexplored. We investigated these aspects using the large UK Biobank's population-based cohort, which provided clinical history through ICD-10 diagnosis codes.

methodsWe assessed associations between 600 clinical conditions and MS risk in 477,421 individuals using Cox models adjusted for demographics, smoking, and MS polygenic risk score (MS-PRS). Statistically significant conditions were included in a LASSO Cox regression (five-fold cross-validation on 70% training set) to identify key predictors, with performance assessed by the C-index and age-dependent area under the curve (AUC) in the 30% test set. Lastly, temporal trajectories of MS-associated conditions were analyzed in MS cases.

resultsWe identified 192 conditions associated with MS, of which only ~20% were onset symptoms. Integrating these conditions into a predictive model already including demographics and smoking, improved the C-index from 0.65 to 0.71. Among the 30 model-selected best predictors, ~25% were prodromal conditions, including neuromuscular diseases, thromboembolism, and depression which typically occurred more than five years before MS diagnosis. Including MS-PRS further increased the C-index to 0.78, with an age-dependent AUC exceeding 0.80 in individuals over 50 years. Trajectory analysis highlighted migraine as a common early diagnosis, often followed by hypertension, depression, and dorsalgia.

interpretationOur findings highlight early conditions and diagnostic trajectories of MS, supporting the existence of a prodromal phase. These insights could improve MS prediction and facilitate earlier detection, particularly for late-onset cases.

Indexed as

Multiple SclerosisProdromal SymptomsAdultAgedBiological Specimen BanksCohort StudiesFemaleHumansMaleMiddle AgedPredictive Value of TestsTime FactorsUK BiobankUnited Kingdomcomorbiditiesmultiple sclerosispredictionprodrome

Identifiers

PMID40574489
PMCPMC12516241

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.